🎁 Black Friday: up to 50% off of annual plans
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.200
-0.140 (-5.98%)
At close: Nov 20, 2026, 4:00 PM EST
2.298
+0.098 (4.47%)
After-hours: Nov 20, 2026, 7:59 PM EST

Ovid Therapeutics Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Ovid Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $6.15. The average 1-year stock price forecast is 179.55% higher than the current stock price, while the lowest is $4.00 (+81.82%) and the highest is $9.00 (+309.09%).

Price Target: $6.15 (+179.55%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.00$6.15$5.25$9.00
Change+81.82%+179.55%+138.64%+309.09%

Analyst Ratings

The average analyst rating for Ovid Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy101010101313
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total101010101313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Guggenheim
No rating
Guggenheim
Buy
Reiterates
$7
BuyReiterates$7+218.18%Nov 13, 2026
Roth MKM
Roth MKM
Buy
Reiterates
$8 → $5.5
BuyReiterates$8 → $5.5+150.00%Nov 12, 2026
BTIG
BTIG
Buy
Maintains
$4
BuyMaintains$4+81.82%Nov 12, 2026
Wolfe Research
Wolfe Research
Buy
Initiates
$5
BuyInitiates$5+127.27%Oct 15, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$6
BuyInitiates$6+172.73%Oct 9, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
788.25K
from 7.25M
Decreased by -89.13%
Revenue Next Year
191.00K
from 788.25K
Decreased by -75.77%
EPS This Year
-0.40
from -0.23
EPS Next Year
-0.40
from -0.40
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
208.38M1.50M392.00K566.00K7.25M788.25K
Revenue Growth
1,551.57%-99.28%-73.91%44.39%1,181.27%-89.13%
Gross Profit
208.38M1.50M392.00K566.00K7.25M788.25K
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Income
124.21M-55.55M-57.58M-58.39M-42.44M-77.94M
Net Income
122.83M-54.17M-52.34M-26.43M-17.41M-73.66M
EPS
-----0.23-0.40
Free Cash Flow
-----38.33M-67.93M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.5M
Avg788,250
Low700,000

Revenue Growth

Revenue Growth202620272028
High
-80.0%
Avg
-89.1%
Low
-90.3%

EPS Forecast

EPS202620272028
High-0.36
Avg-0.40
Low-0.45

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-